2022-500902-16-00已完成1 期
A Phase I study to evaluate the safety and dosimetry of 68Ga-labelled OncoFAP derivatives in patients with solid tumors
Philogen S.p.A., Philogen S.p.A.5 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年11月9日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
- 试验地点
- 5
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Jacqueline Mock
Scientific
Philogen S.p.A.
研究点 (5)
Loading locations...
相似试验
已完成
不适用
A phase I study to evaluate the safety and pharmacokinetics of TRN501 in healthy adult Japanese male volunteers.Parkinson's diseasejRCT2031230689SNLD, Ltd.72
招募中
1 期
Phase 1 study to examine the safety and dose-dependent effect of rapamycin topical medicine on perspiration in healthy volunteershyperhidrosisJPRN-UMIN000016525Department of Dermatology Graduate School of Medicine, Osaka University12
已完成
1 期
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid TumorsAdvanced Solid TumorsJPRN-jRCT2080223391AstraZeneca6
进行中（未招募）
不适用
A study to evaluate the safety of panitumumab and children with solid tumoursEUCTR2014-005190-36-Outside-EU/EEAAmgen Inc36
招募中
1 期
A Phase I Study to Evaluate the Safety and Efficacy of Mesenchymal Stromal Cells (MSC) for Treating Chronic Obstructive Pulmonary Disease (COPD)COPDRespiratory - Chronic obstructive pulmonary diseaseACTRN12614000731695Royal Perth Hospital10